Insights on the Cognitive and Memory Enhancer Drugs Global Market to 2030 - High Incidence of Neurodegenerative Disorders is Driving Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cognitive and Memory Enhancer Drugs Market by Product, Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The global cognitive and memory enhancer drug market was valued at $5,079.86 million in 2020, and is projected to reach $8,689.74 million by 2030, registering a CAGR of 5.5% from 2021 to 2030.

Cognitive and memory enhancer drugs, supplements, and other substances are claimed to improve cognitive function, particularly executive functions, attention, memory, creativity, or motivation, in healthy individuals. These drugs include a number of different kinds of substances that can increase mental performance and capable of improving or preserving memory, of potentiating learning, or of preventing cognitive decline or dementia.

The major factors that contribute to the market growth include a surge in the geriatric population, which is highly prone to neurological disorders such as Alzheimer's. Moreover, rise in adoption of cognitive drugs, owing to their benefits such as improved physical and mental performance, boosts the market growth. However, ethical issues related with the use of such drugs restrain the growth of this market.

The cognitive and memory enhancer drug market is segmented into product, application, and region. By product, the market is fragmented into Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and others. By application, it is segregated into disease treatment, education, sports, and others. Region wise, the cognitive and memory enhancer drug market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

• The report provides an in-depth analysis of the global cognitive and memory enhancer drug market size along with the current trends and future estimations to elucidate the imminent investment pockets
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
• A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global cognitive and memory enhancer drug market

Market Dynamics

Drivers

• Rapid Growth of Geriatric Population
• High Incidence of Neurodegenerative Disorders
• Benefits of Smart Drugs

Restraint

• Numerous Ethical Issues

Opportunity

• Effective Strength of the Drugs

Key Market Segments

By Product

• Aricept
• Exelon
• Namenda
• Razadyne
• Provigill
• Ritalin
• Adderall
• Others

By Application

• Disease Treatment
• Education
• Sports
• Others

By Region

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

Key Market Players

• AbbVie
• Alterna Script LLC
• Ceretropic
• Eisai Co Ltd
• Johnson & Johnson
• Novartis International AG
• Pfizer Inc
• Takeda Pharmaceutical Company Ltd
• GlobalMed
• Teva Pharmaceutical Industries Ltd. (Cephalon Inc)

For more information about this report visit https://www.researchandmarkets.com/r/wn8v67

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900